Log in
Enquire now
ProQR Therapeutics

ProQR Therapeutics

ProQR Therapeutics is a developer of RNA therapy for Rett syndrome founded in 2012 by Henri Termeer, Daniel de Boer, Gerard Platenburg and Dinko Valerio.

OverviewStructured DataIssuesContributors

Contents

proqr.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
0
Therapeutics
Therapeutics
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
Technology
Technology
...
Location
Palo Alto, California
Palo Alto, California
Leiden
Leiden
0
Netherlands
Netherlands
0
Cambridge, Massachusetts
Cambridge, Massachusetts
United States
United States
B2X
B2B
B2B
0
B2C
B2C
CEO
Daniel de Boer
Daniel de Boer
0
Founder
Gerard Platenburg
Gerard Platenburg
0
Dinko Valerio
Dinko Valerio
0
Henri Termeer
Henri Termeer
0
Daniel de Boer
Daniel de Boer
0
Pitchbook URL
pitchbook.com/profiles.../61956-10
Legal Name
ProQR Therapeutics N.V.0
Date Incorporated
2016
Number of Employees (Ranges)
51 – 200
Email Address
info@proqr.com0
Phone Number
+318816670000
Full Address
245 Main Street (2nd Floor) Cambridge, MA 02142 USA0
ZERNIKEDREEF 9, LEIDEN, Netherlands, 2333 CK0
CIK Number
1,612,9400
Investors
Gilde Healthcare
Gilde Healthcare
Sofinnova Partners
Sofinnova Partners
‌
Rett Syndrome Research Trust
DUNS Number
4904377520
Founded Date
2012
0
Total Funding Amount (USD)
58,444,140
Latest Funding Round Date
December 11, 2024
Exchange
Nasdaq
Nasdaq
0
Latest Funding Type
Series A
Series A
CAGE Code
H2F050
Patents Assigned (Count)
12
Technologies Used
CRISPR
CRISPR
Country
United States
United States
0
Netherlands
Netherlands
0
Headquarters
Leiden
Leiden
0

Other attributes

Blog
proqr.com/community-...es-and-news
Company Operating Status
Active
Contact Page URL
proqr.com/contact
Latest Funding Round Amount (USD)
8,100,000
Previous Name
ProQR Therapeutics B.V.0
Public/Private
Public0
SIC Code
2,8340
Ticker Symbol
PRQR0
Wikidata ID
Q30288538

ProQR Therapeutics is a biotechnology company that is committed to changing lives. It focuses on developing RNA therapies for persons that are living with inherited retinal disease (IRD) to regain vision.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ProQR Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.